Muscarinic receptor compensation in hippocampus of Alzheimer patients

J Neural Transm. 1983;56(1):13-9. doi: 10.1007/BF01243370.

Abstract

The activity of the acetylcholine synthesizing enzyme choline acetyltransferase (ChAT) (presynaptic marker) and number of muscarine-like receptor binding sites have been measured in the hippocampus from eight individuals with senile dementia of Alzheimer type (SDAT) and ten controls. A negative correlation (r = 0.80; p less than 0.05) was found between the ChAT activity and the number of muscarine-like receptors in the SDAT group but not in the controls. The findings might indicate an ongoing compensatory receptor mechanism as a response to changes in presynaptic cholinergic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / enzymology
  • Alzheimer Disease / metabolism*
  • Antipsychotic Agents / therapeutic use
  • Choline O-Acetyltransferase / metabolism
  • Dementia / metabolism*
  • Hippocampus / analysis*
  • Hippocampus / enzymology
  • Humans
  • Male
  • Quinuclidinyl Benzilate
  • Receptors, Cholinergic / analysis*
  • Receptors, Muscarinic / analysis*

Substances

  • Antipsychotic Agents
  • Receptors, Cholinergic
  • Receptors, Muscarinic
  • Quinuclidinyl Benzilate
  • Choline O-Acetyltransferase